Vanguard Group Inc Ocuphire Pharma, Inc. Transaction History
Vanguard Group Inc
- $6.44 Trillion
- Q3 2025
A detailed history of Vanguard Group Inc transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,342,025 shares of OCUP stock, worth $1.32 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,342,025
Previous 992,200
35.26%
Holding current value
$1.32 Million
Previous $972,000
35.29%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding OCUP
# of Institutions
53Shares Held
19.2MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.01% of portfolio
-
Bios Capital Management, LP Fort Worth, TX3.68MShares$3.61 Million7.42% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.35MShares$3.28 Million0.13% of portfolio
-
Mink Brook Asset Management LLC West Palm Beach, FL1.24MShares$1.21 Million1.38% of portfolio
-
Opaleye Management Inc. Boston, MA1.1MShares$1.08 Million0.18% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...